AVI BioPharma Tumbles After Pricing IPO (AVII)
Shares of AVI BioPharma (NASDAQ:AVII) were trading down nearly 18% Friday after the company prices a 20 million share public offering at $1.50 per share.That share-offering price is nearly 20% lower than the stock's close yesterday of $1.86 per share.The public offering is expected to close on or about next Thursday, April 6th.
Credit: Financial News Network
Published by Grab Networks
A resource for website publishers who want to embed quality, licensed content on a wide variety of topics. View profile



